APA

Elnaggar M. H., Abushouk A. I., Hassan A. H. E., Lamloum H. M., Benmelouka A., Moatamed S. A., Abd-Elmegeed H., Attia S., Samir A., Amr N., Johar D. & Zaky S. (20220303). Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. : Seminars in cancer biology.

Chicago

Elnaggar Muhammed H, Abushouk Abdelrahman I, Hassan Ahmed H E, Lamloum Hadeer M, Benmelouka Amira, Moatamed Shurouk A, Abd-Elmegeed Hossam, Attia Somia, Samir Aya, Amr Nouran, Johar Dina and Zaky Samy. 20220303. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. : Seminars in cancer biology.

Harvard

Elnaggar M. H., Abushouk A. I., Hassan A. H. E., Lamloum H. M., Benmelouka A., Moatamed S. A., Abd-Elmegeed H., Attia S., Samir A., Amr N., Johar D. and Zaky S. (20220303). Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. : Seminars in cancer biology.

MLA

Elnaggar Muhammed H, Abushouk Abdelrahman I, Hassan Ahmed H E, Lamloum Hadeer M, Benmelouka Amira, Moatamed Shurouk A, Abd-Elmegeed Hossam, Attia Somia, Samir Aya, Amr Nouran, Johar Dina and Zaky Samy. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma. : Seminars in cancer biology. 20220303.